Wealth Enhancement Trust Services’s CareDx CDNA Stock Holding History

Wealth Enhancement Trust Services’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$200	Buy	+7	New	+$152	﹤0.01%	1359

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Wealth Enhancement Trust Services's CDNA Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in CareDx (CDNA) in Q2 2026: 7 shares worth $200. The stake represents ﹤0.01% of the portfolio and ranks #1359 among its holdings.

113 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

Wealth Enhancement Trust Services held 7 shares of CareDx worth $200 as of Q2 2026.
CareDx was a new Wealth Enhancement Trust Services position in Q2 2026.
CareDx made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1359 holding.
113 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.